[SRNE] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 2.48%
YoY- -26.21%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 15,594 13,076 11,505 13,034 6,929 20,407 4,019 25.34%
PBT -210,499 -178,068 -73,068 -69,110 -55,746 -38,001 -12,724 59.59%
Tax -1,814 -33,055 36 309 -3,122 -90,424 -701 17.16%
NP -223,692 -144,417 -71,502 -62,820 -49,776 12,425 -11,957 62.89%
Tax Rate - - - - - - - -
Total Cost 239,286 157,493 83,007 75,854 56,705 7,982 15,976 56.97%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,434.47 -1,104.44 -621.49 -481.97 -718.37 60.89 -297.51 29.96%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 0.00 -0.47 -0.28 -0.34 -0.41 0.15 -0.23 -
EPS Diluted 0.00 -0.47 -0.28 -0.34 -0.41 0.15 -0.23 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.